Muhammad Wasif Saif

9PUBLICATIONS
9CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 11, 2026
Ranking targeted therapies in advanced pancreatic adenocarcinoma: insights from a network meta-analysis.

|Nov 27, 2025
An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

Khalil Choucair, Roupen Odabashian, Sushmita Nanja Reddy

|Jul 12, 2025
TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients.

Muhammad Wasif Saif, Wen-Han Chang, Scott Myers

|Jun 07, 2021
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.

Muhammad Wasif Saif, Carlos R Becerra, Marwan G Fakih

|Apr 01, 2021
Association of Pharmacogenetics With Adverse Events of Fluorouracil/Capecitabine in Patients With Cancer.

Daniel A King, Robert B Diasio, M Wasif Saif

|Oct 29, 2020
Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity.

Muhammad Wasif Saif

Pageof 2

Frequent Collaborators

1 joint publications

Daniel A King

1 joint publications

Robert B Diasio

1 joint publications

Manish M Karamchandani

1 joint publications

Tej Ganti